| |
| Issue |
Title |
| |
| Vol 23, No 1 (2013) |
Efficacy of pegylated interferon alfa-2b «Algeron» in the treatment of chronic hepatitis C |
Abstract
PDF (Rus)
|
|
M. V. Mayevskaya, O. O. Znoyko, E. A. Klimova, S. L. Maximov, S. N. Kizhlo, N. A. Petrochenkova, F. I. Nagimova, R. A. Ivanov, Yu. N. Linkova, T. V. Chernovskaya |
| |
| Vol 23, No 1 (2013) |
The impact of the ursodeoxycholic acid as monotherapy and in the combination with the lactulose on the biochemical blood tests values of the nonalcoholic steatohepatitis patients |
Abstract
PDF (Rus)
|
|
I. V. Mayev, Yu. A. Kucheryavyy, S. V. Morozov, M. G. Saidullayeva, M. L. Akhtayeva, N. Yu. Stukova, E. A. Krasnyakova |
| |
| Vol 24, No 6 (2014) |
Hypercoagulation syndrome at liver cirrhosis |
Abstract
PDF (Rus)
|
|
I. A. Kurkina, M. V. Mayevskaya, B. V. Silayev, V. T. Ivashkin |
| |
| Vol 24, No 6 (2014) |
Liver fibrosis and markers of endothelial function at metabolic syndrome and early disorders of carbohydrate metabolism |
Abstract
PDF (Rus)
|
|
L. V. Chesnokova, I. M. Petrov, Ye. A. Sidorova, I. A. Troshina, Yu. A. Petrova |
| |
| Vol 24, No 5 (2014) |
Mediators of intercellular interactions and histological signs of chronic viral liver disease |
Abstract
PDF (Rus)
|
|
P. V. Koroy, A. V. Yagoda, G. I. Gilyazova, I. S. Mukhoramova |
| |
| Vol 24, No 5 (2014) |
Modern modes of chronic hepatitis B treatment in daily clinical practice |
Abstract
PDF (Rus)
|
|
M. V. Mayevskaya, M. A. Morozova, S. A. Ondos, V. T. Ivashkin |
| |
| Vol 24, No 5 (2014) |
Principles of effective out-patient diagnostics of diffuse liver diseases |
Abstract
PDF (Rus)
|
|
Komova A. G., M. V. Mayevskaya, V. T. Ivashkin |
| |
| Vol 24, No 4 (2014) |
Improvement of non-alcoholic fatty liver disease treatment |
Abstract
PDF (Rus)
|
|
P. I. Seliverstov, V. G. Radchenko |
| |
| Vol 24, No 4 (2014) |
Diagnostics of hepatocellular cancer: state-of-the-art |
Abstract
PDF (Rus)
|
|
T. Yu. Danzanova, G. T. Sinyukova, P. I. Lepedatu |
| |
| Vol 24, No 4 (2014) |
Interferon-free therapy of chronic hepatitis C: replacement of medications or new treatment paradigm? |
Abstract
PDF (Rus)
|
|
S. N. Batskikh |
| |
| Vol 24, No 4 (2014) |
Epidemiologic features of non-alcoholic fatty liver disease in Russia |
Abstract
PDF (Rus)
|
|
O. M. Drapkina, V. T. Ivashkin |
| |
| Vol 24, No 3 (2014) |
Genetic polymorphism of hepatitis C virus and risk of hepatocellular carcinoma |
Abstract
PDF (Rus)
|
|
S. N. Mammayev, A. M. Karimova |
| |
| Vol 24, No 3 (2014) |
Association of leptin receptor Gln223Arg genetic polymorphism with obesity and non-alcoholic fatty liver disease |
Abstract
PDF (Rus)
|
|
A. V. Morozova, N. V. Mal'tseva, Y. A. Gorbatovsky, O. F. Lykova, S. V. Arkhipova |
| |
| Vol 26, No 1 (2016) |
Hepatic encephalopathy: pathogenesis, clinical presentation, diagnostics, treatment |
Abstract
PDF (Rus)
|
|
Ch. S. Pavlov, I. V. Damulin, V. T. Ivashkin |
| |
| Vol 26, No 1 (2016) |
Nosological aspects of hepatomegaly and splenomegaly at pediatric age |
Abstract
PDF (Rus)
|
|
M. M. Kotovich, F. K. Manerov, E. V. Luchsheva |
| |
| Vol 26, No 2 (2016) |
The issue of clinical application of non-invasive evaluation of liver fibrosis at chronic hepatitis B |
Details
PDF (Rus)
|
|
Chavdar S. Pavlov, Ye. A. Kuznetsova, M. Ch. Semenistaya, M. V. Mayevskaya, V. T. Ivashkin |
| |
| Vol 26, No 2 (2016) |
Diagnostics and treatment of non-alcoholic fatty liver disease: clinical guidelines of the Russian Scientific Liver Society and the Russian gastroenterological association |
Details
PDF (Rus)
|
|
V. T. Ivashkin, Marina V. Mayevskaya, Ch. S. Pavlov, I. N. Tikhonov, Ye. N. Shirokova, A. O. Buyeverov, O. M. Drapkina, Yu. O. Shulpekova, V. V. Tsukanov, S. N. Mammayev, I. V. Mayev, L. K. Palgova |
| |
| Vol 26, No 3 (2016) |
Rare forms of nonalcoholic fatty liver disease: hereditary lysosomal acid lipase deficiency |
Abstract
PDF (Rus)
|
|
M. V. Mayevskaya, V. T. Ivashkin, M. S. Zharkova, T. P. Nekrasova, G. I. Ayusheva, R. V. Maslennikov |
| |
| Vol 26, No 3 (2016) |
Noninvasive diagnostic methods of liver fibrosis in patients with primary biliary cirrhosis and primary sclerosing cholangitis: role of indirect serological markers |
Abstract
PDF (Rus)
|
|
A. F. Sheptulina, Ye. N. Shirokova, V. T. Ivashkin |
| |
| Vol 25, No 6 (2015) |
Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results |
Abstract
PDF (Rus)
|
|
V. T. Ivashkin, O. M. Drapkina, I. V. Mayev, A. S. Trukhmanov, D. V. Blinov, L. K. Palgova, V. V. Tsukanov, T. I. Ushakova |
| |
| Vol 25, No 6 (2015) |
NS5A replication complex inhibitor daclatasvir in the basis of chronic hepatitis C interferon-free therapy |
Abstract
PDF (Rus)
|
|
M. V. Mayevskaya, M. S. Zharkova, V. T. Ivashkin |
| |
| Vol 25, No 6 (2015) |
The perspectives of autologous hepatocytes generation for the treatment of liver failure |
Abstract
PDF (Rus)
|
|
M. N. Evseeva, A. F. Sheptulina, Yu. P. Rubtsov |
| |
| Vol 25, No 6 (2015) |
Computer-tomography features of hemodynamics in hepatocellular carcinoma foci depend on the stage of histological differentiation |
Abstract
PDF (Rus)
|
|
U. N. Tumanova, N. I. Yashina, Ye. A. Dubova, G. G. Karmazanovsky, A. I. Schegolev |
| |
| Vol 25, No 5 (2015) |
Treatment response rate and life prognosis at autoimmune liver diseases |
Abstract
PDF (Rus)
|
|
K. V. Ivashkin, Ye. N. Shirokova, V. T. Ivashkin |
| |
| Vol 25, No 5 (2015) |
New strategies in management of severe alcoholic hepatitis |
Abstract
PDF (Rus)
|
|
P. Ye. Tkachenko, , I. I. Komkova, M. V. Mayevskaya, V. T. Ivashkin |
| |
| Vol 25, No 4 (2015) |
Viral hepatitis B epidemiology in Sakha republic (Yakutia) |
Abstract
PDF (Rus)
|
|
S. I. Semenov, R. G. Savvin, S. G. Nikitina, S. S. Maksimova, V. G. Krivoshapkin, S. S. Sleptsova |
| |
| Vol 25, No 4 (2015) |
New aspects of non-alcoholic fatty liver disease |
Abstract
PDF (Rus)
|
|
V. V. Tsukanov, E. V. Kasparov, Yu. L. Tonkikh, A. V. Vasyutin |
| |
| Vol 25, No 4 (2015) |
Methodical approaches in experimental modelling of non-alcoholic fatty liver disease |
Abstract
PDF (Rus)
|
|
N. V. Bivalkevich, Yu. K. Denisenko, T. P. Novgorodtseva |
| |
| Vol 25, No 4 (2015) |
Change of liver enzymes level during follow-up of patients exposed to vinylchloride |
Abstract
PDF (Rus)
|
|
I. V. Kudayeva, L. A. Budarina, O. A. Dyakovich |
| |
| Vol 25, No 3 (2015) |
Alcohol-induced liver disease: primary and secondary prevention |
Abstract
PDF (Rus)
|
|
S. V. Plyusnin, K. V. Ivashkin, A. N. Bobrov, S. A. Belyakin, I. V. Plyusnina |
| |
| Vol 25, No 3 (2015) |
Hyperhomocisteinemia, hypercysteinemia, glutamate excitotoxicity, taurine deficiency at hepatitis C |
Abstract
PDF (Rus)
|
|
V. K. Pozdeev, N. V. Pozdeev, O. Ye. Nikitina |
| |
| Vol 25, No 2 (2015) |
Non-invasive of liver fibrosis diagnostics: the role of serum markers |
Abstract
PDF (Rus)
|
|
A. F. Sheptulina, Ye. N. Shirokova, V. T. Ivashkin |
| |
| Vol 25, No 1 (2015) |
Effect of weight loss on the course of non-alcoholic fatty liver disease: results of 6-month follow-up |
Abstract
PDF (Rus)
|
|
L. V. Chesnokova, I. M. Petrov, I. A. Troshina, M. V. Goncharova, I. V. Medvedeva |
| |
| Vol 25, No 1 (2015) |
B-cell non-Hodgkin's lymphoma in the patient with chronic hepatitis C and mixed cryoglobulinemia |
Abstract
PDF (Rus)
|
|
V. S. Adonyeva, Ye. A. Kolodyazhnaya, A. B. Bochkarev |
| |
| Vol 24, No 2 (2014) |
Triple antiviral therapy in patient with liver cirrhosis: complications and options of pharmacological treatment |
Abstract
PDF (Rus)
|
|
M. V. Mayevskaya, I. N. Tikhonov, V. T. Ivashkin |
| |
| Vol 24, No 2 (2014) |
Treatment of chronic hepatitis C by cepeginterferon alpha-2b in combination to ribavirin |
Abstract
PDF (Rus)
|
|
M. V. Mayevskaya, O. O. Znoyko, Ye. A. Klimova, S. L. Maximov, S. N. Kizhlo, N. A. Petrochenkova, F. I. Nagimova, Yu. N. Linkova |
| |
| Vol 24, No 2 (2014) |
Russian interferon α-2b drug in the treatment of chronic hepatitis C |
Abstract
PDF (Rus)
|
|
N. B. Kovaleva |
| |
| Vol 24, No 2 (2014) |
Polymorphism of renin — angiotensin system genes in progression of liver fibrosis in patients with chronic hepatitis C |
Abstract
PDF (Rus)
|
|
O. V. Taratina, T. N. Krasnova, L. M. Samokhodskaya, T. N. Lopatkina, V. A. Tkachuk, N. A. Mukhin |
| |
| Vol 24, No 1 (2014) |
Drug-induced liver injuries |
Abstract
PDF (Rus)
|
|
S. F. Galimova |
| |
| Vol 24, No 1 (2014) |
Asymptomatic elevation of serum aminotransferase activity: stages of diagnostic search |
Abstract
PDF (Rus)
|
|
Yu. A. Tereshchenko, S. Yu. Tereshchenko |
| |
| Vol 24, No 1 (2014) |
Safety and efficacy of telaprevir in treatment of a chronic hepatitis C in patients of the Russian population included in early access program study |
Abstract
PDF (Rus)
|
|
D. T. Abrurakhmanov, V. G. Morozov, I. G. Nikitin, P. O. Bogomolov, N. I. Geyvandova, Ye. N. Bessonova, I. G. Bakulin, V. A. Isakov, K. V. Zhdanov, M. V. Mayevskaya, Ye. A. Nurmukhametova, E. Z. Burnevich, Ye. V. Chesnokov, V. D. Pasechnikov, A. Hill, I. Lonjon-Domanec, S. N. Kizhlo |
| |
| Vol 24, No 1 (2014) |
Efficacy and safety of the first domestic pegilated interferon alpha-2b «Pegaltevir» at chronic hepatitis C: pilot data of phase III clinical study |
Abstract
PDF (Rus)
|
|
V. T. Ivashkin, Ye. N. Bessonova, P. O. Bogomolov, N. I. Geyvandova, K. V. Zhdanov, M. V. Mayevskaya, V. G. Morozov, V. D. Pasechnikov, I. Yu. Khomenko, A. V. Yagoda |
| |
| Vol 23, No 6 (2013) |
Efficacy and safety of new protease inhibitor faldaprevir in treatment of hepatitis C |
Abstract
PDF (Rus)
|
|
M. V. Mayevskaya, M. S. Zharkova, V. T. Ivashkin |
| |
| Vol 23, No 6 (2013) |
Alcohol, alcoholism and related consequences |
Abstract
PDF (Rus)
|
|
M. V. Mayevskaya |
| |
| Vol 23, No 6 (2013) |
Outcomes of the toxic hepatites caused by alcohol surrogates |
Abstract
PDF (Rus)
|
|
I. Yu. Pirogova, I. Yu. Ponomareva, S. P. Sinitsyn, Ye. P. Samokhina, A. S. Gorbunova, Ye. Yu. Startseva, V. S. Chulkov, T. F. Kondrat'yeva |
| |
| Vol 23, No 6 (2013) |
Experience of enrollment and management of the Waiting list for liver transplantation at hepatological center |
Abstract
PDF (Rus)
|
|
Ye. N. Bessonova, O. A. Stroganova, Yu. A. Glazyrina, I. A. Kornilova |
| |
| Vol 23, No 5 (2013) |
Nuclear receptors in regulation of bile acids transport and metabolism |
Abstract
PDF (Rus)
|
|
A. F. Sheptulina, Ye. N. Shirokova, V. T. Ivashkin |
| |
| Vol 23, No 5 (2013) |
Telaprevir: options of application in separate patient groups |
Abstract
PDF (Rus)
|
|
M. V. Mayevskaya, I. N. Tikhonov, V. T. Ivashkin |
| |
| Vol 23, No 5 (2013) |
Terlipressin at esophageal varicose bleeding at liver cirrhosis with portal hypertension syndrome |
Abstract
PDF (Rus)
|
|
B. N. Kotiv, I. I. Dzidzava, D. P. Kashkin, A. V. Smorodsky, A. V. Slobodyanik, S. A. Soldatov, M. V. Koldin |
| |
| Vol 23, No 4 (2013) |
Long-term results of antiviral therapy in patients with chronic hepatitis C with sustained virologic response |
Abstract
PDF (Rus)
|
|
T. M. Ignatova, T. N. Lopatkina, V. P. Chulanov, Ye. V. Gaydasheva, S. N. Batskikh, G. V. Mikhaylovskaya, D. T. Abdurakhmanov, S. Yu. Karpov, Ye. N. Nikulkina, O. A. Chernova |
| |
| Vol 23, No 4 (2013) |
Budesonide in treatment of alcohol-induced severe hepatitis: results of randomized trial |
Abstract
PDF (Rus)
|
|
I. I. Komkova, M. V. Mayevskaya, V. T. Ivashkin |
| |
| Vol 23, No 4 (2013) |
Polymorphism of genes and drug-induced liver injury |
Abstract
PDF (Rus)
|
|
P. Ye. Tkachenko, M. V. Mayevskaya, V. T. Ivashkin |
| |
| Vol 23, No 3 (2013) |
Klatskin tumor (Review of literature) |
Abstract
PDF (Rus)
|
|
I. V. Mayev, D. T. Dicheva, D. N. Andreyev, T. V. Penkina |
| |
| Vol 23, No 3 (2013) |
Critical evaluation of pathogenic factors of primary biliary cirrhosis |
Abstract
PDF (Rus)
|
|
A. F. Sheptulina, M. V. Mayevskaya, V. T. Ivashkin |
| |
| Vol 23, No 3 (2013) |
Risk of progression and the cause of mortality at chronic viral mixed-hepatitis |
Abstract
PDF (Rus)
|
|
K. I. Yesmembetov, D. T. Abdurakhmanov, A. V. Odintsov, N. A. Mukhin |
| |
| Vol 23, No 3 (2013) |
The prognostic value of ferritinemia level in patients with chronic hepatitis C |
Abstract
PDF (Rus)
|
|
N. C. Sargsyants, E. H. Grigoryan |
| |
| Vol 23, No 3 (2013) |
Chronic glomerulonephritis of the mixed type in patient with HBV-infection (Clinical case) |
Abstract
PDF (Rus)
|
|
V. S. Adonyeva, A. B. Botchkarev, O. S. Saurina |
| |
| Vol 23, No 2 (2013) |
Chronic hepatitis B and risk of kidney involvement |
Abstract
PDF (Rus)
|
|
M. V. Mayevskaya, I. N. Tikhonov, V. T. Ivashkin |
| |
| Vol 23, No 2 (2013) |
Case of acute drug-induced hepatitis after halothane anesthesia |
Abstract
PDF (Rus)
|
|
I. Yu. Pirogova, Ye. V. Berestova, O. Yu. Bastrikov, Ye. B. Kovaleva, T. P. Petukhova, M. V. Guseva, I. A. Gubina, I. V. Rezepin, S. P. Sinitsyn |
| |
| Vol 22, No 6 (2012) |
Hemorrhagic syndrome at liver cirrhosis |
Abstract
PDF (Rus)
|
|
I. A. Kurkina, O. S. Volkova, M. V. Mayevskaya, V. T. Ivashkin |
| |
| Vol 22, No 6 (2012) |
Two ways to one goal: new strategy of antiviral therapy for chronic hepatitis C |
Abstract
PDF (Rus)
|
|
S. N. Batskikh |
| |
| Vol 22, No 6 (2012) |
Results of the ORION open comparative randomized trial: evaluation of efficacy of the Russian drugs Altevir and Phosphogliv in combined treatment of chronic hepatitis C |
Abstract
PDF (Rus)
|
|
V. T. Ivashkin, M. V. Mayevskaya, P. O. Bogomolov, I. G. Nikitin, A. O. Buyeverov, A. V. Lapshin |
| |
| Vol 22, No 6 (2012) |
Diastolic dysfunction of myocardium and change of Q–T interval at chronic hepatitis C |
Abstract
PDF (Rus)
|
|
A. A. Konysheva, Ye. A. Saginova, S. V. Moiseyev, T. N. Krasnova, D. T. Abdurakhmanov |
| |
| Vol 22, No 5 (2012) |
Autoimmune hepatitis: new in diagnostics, a pathogenesis and treatment |
Abstract
PDF (Rus)
|
|
Ye. N. Shirokova, K. V. Ivashkin, V. T. Ivashkin |
| |
| Vol 22, No 5 (2012) |
Principles of portal hypertension treatment at patients with liver cirrhosis |
Abstract
PDF (Rus)
|
|
Ye. A. Fedosina, M. V. Mayevskaya, V. T. Ivashkin |
| |
| Vol 22, No 5 (2012) |
The effect of bacterial overgrowth syndrome and bacterial translocation on the course of liver cirrhosis |
Abstract
PDF (Rus)
|
|
M. S. Zharkova, M. V. Mayevskaya, V. T. Ivashkin |
| |
| Vol 22, No 5 (2012) |
Pegilated interferon α2а in treatment of chronic hepatitis C |
Abstract
PDF (Rus)
|
|
P. O. Bogomolov, S. V. Koblov, A. O. Buyeverov, M. V. Matsiyevich, O. S. Kuzmina, N. A. Barsukova, N. V. Dubinina |
| |
| Vol 22, No 4 (2012) |
Telaprevir in treatment of chronic hepatitis C: safety issues |
Abstract
PDF (Rus)
|
|
T. M. Ignatova |
| |
| Vol 22, No 4 (2012) |
Issues occult hepatitis B virus infection |
Abstract
PDF (Rus)
|
|
I. A. Morozov, L. Yu. Ilchenko, N. I. Gromova, I. G. Fyedorov, I. V. Gordeychuk, A. K. Knyazhentseva, E. V. Zverkova, M. I. Mikhaylov |
| |
| Vol 22, No 3 (2012) |
Role of alpha-fetoprotein in complex diagnostics of progressing course of chronic hepatitis B and C |
Abstract
PDF (Rus)
|
|
I. A. Belavina, O. P. Dudanova |
| |
| Vol 22, No 3 (2012) |
Drug-induced liver injuries (Part 1) |
Abstract
PDF (Rus)
|
|
S. F. Galimova |
| |
| Vol 22, No 3 (2012) |
Liver diseases (Review of the Seventeenth Russian Gastroenterological Week proceedings, October, 10–12, 2011, Moscow) |
Abstract
PDF (Rus)
|
|
I. V. Mayev, A. N. Kazyulin, Yu. A. Kucheryavy, Ye. A. Mayevskaya |
| |
| Vol 22, No 2 (2012) |
Methods of risk prediction and monitoring of treatment response rate of bleedings from esophageal varices in patients with liver cirrhosis |
Abstract
PDF (Rus)
|
|
D. V. Garbuzenko |
| |
| Vol 22, No 2 (2012) |
Prevalence of non-alcoholic fatty liver disease at obesity and its interrelation with cardio-vascular disease and 2nd type diabetes mellitus risk factors |
Abstract
PDF (Rus)
|
|
G. A. Melnichenko, A. Yu. Yeliseyeva, M. V. Mayevskaya |
| |
| Vol 22, No 2 (2012) |
HВcorAg expression in HВeАg-negative hepatitis: correlation to clinical and histological activity and HВsAg-status |
Abstract
PDF (Rus)
|
|
O. P. Dudanova, I. A. Pravdolyubova |
| |
| Vol 22, No 1 (2012) |
Modern modes of chronic hepatitis C treatment |
Abstract
PDF (Rus)
|
|
V. T. Ivashkin, M. V. Mayevskaya, M. A. Morozova, Ye. O. Lyusina |
| |
| Vol 22, No 1 (2012) |
Pathogenic role of lipids in non-alcoholic fatty liver disease |
Abstract
PDF (Rus)
|
|
Yu. O. Shulpekova |
| |
| Vol 21, No 6 (2011) |
Recent trends in studying of alcohol-induced liver disease |
Abstract
PDF (Rus)
|
|
I. I. Komkova, M. S. Zharkova, M. V. Mayevskaya |
| |
| Vol 21, No 6 (2011) |
Infiltration of the liver by cells of innate and adaptive immunity and their destruction in development of experimental immune concanavalin-A-induced hepatitis |
Abstract
PDF (Rus)
|
|
S. I. Pavlovich, T. M. Bryzgina, N. V. Makogon, L. I. Aleksyuk, T. V. Martynova, R. I. Yanchy, I. N. Alekseyeva |
| |
| Vol 21, No 6 (2011) |
Interleukin 28B polymorphism impact on early HCV kinetics in HCV-infected liver transplant recipients undergoing antiviral therapy |
Abstract
PDF (Rus)
|
|
V. E. Syutkin, V. P. Chulanov, I. V. Karandashova, V. A. Dolgin, A. O. Chugunov |
| |
| Vol 21, No 6 (2011) |
Algorithm of management of patients with acute cholestatic hepatitis (Clinical case presentation) |
Abstract
PDF (Rus)
|
|
T. A. Deyeva, Ye. N. German, M. V. Mayevskaya, V. T. Ivashkin |
| |
| Vol 21, No 5 (2011) |
Application of dicarbamin in treatment of patients by a chronic hepatitis C |
Abstract
PDF (Rus)
|
|
D. Yu. Konstantinov, Ye. A. Konstantinova, L. L. Popova, E. A. Strebkova, A. A. Suzdaltsev |
| |
| Vol 21, No 5 (2011) |
Efficacy of silymarinum at chronic diffuse liver diseases |
Abstract
PDF (Rus)
|
|
A. V. Matvieiev, E. I. Konyaeva, N. V. Matvieieva |
| |
| Vol 21, No 5 (2011) |
Primary biliary cirrhosis: clinical and laboratory criteria of diagnostics and up-to-date treatment |
Abstract
PDF (Rus)
|
|
L. Yu. Il’chenko, V. I. Reshetn’yak |
| |
| Vol 21, No 5 (2011) |
Experience of entecavir in renal graft recipients with chronic hepatitis B |
Abstract
PDF (Rus)
|
|
M. L. Zubkin, Ye. P. Sel'kova, F. K. Kokoyeva, T. A. Semenenko, V. I. Chervinko, A. N. Kolomoyets, E. M. Balakirev, A. V. Frolov, T. P. Nekrasova |
| |
| Vol 21, No 4 (2011) |
Quantitative dynamic evaluation HBsAg in blood in comparison to viral load level in patients with chronic HBV-monoinfection |
Abstract
PDF (Rus)
|
|
K. R. Dudina, O. O. Znoyko, S. A. Shutko, Ye. A. Klimova, L. Ye. Kuzina, D. M. Braginsky, N. P. Blokhina, N. D. Yushchuk |
| |
| Vol 21, No 4 (2011) |
Potentials of antiviral therapy at patients with liver cirrhosis in an outcome of HCV-infection |
Abstract
PDF (Rus)
|
|
E. N. Bessonova |
| |
| Vol 21, No 4 (2011) |
Preliminary results of open comparative randomized study PHG-M3/P01-09 «ORION» on application of «Phosphogliv» in combined therapy of chronic hepatitis C |
Abstract
PDF (Rus)
|
|
M. V. Mayevskaya |
| |
| Vol 26, No 5 (2016) |
Results of non-interventional observational study of ursodeoxycholic acid in primary biliary cirrhosis |
Abstract
PDF (Rus)
|
|
Yelena N. Shirokova, Anna F. Sheptulina |
| |
| Vol 27, No 6 (2017) |
Non-alcoholic fatty liver disease: comparative assessment of diagnostic and treatment approaches in the Russian Federation and People’s Republic of China |
Abstract
PDF (Rus)
|
|
M. Ch. Semenistaya, Fan Jian-Gao, O. B. Velichenko, Ye. A. Kuznetsova, Ch. S. Pavlov |
| |
| Vol 26, No 6 (2016) |
Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial) |
Abstract
PDF (Rus)
|
|
Marina V. Mayevskaya, Ye. N. Bessonova, P. O. Bogomolov, N. I. Geyvandova, K. V. Zhdanov, V. G. Morozov, V. D. Pasechnikov, I. Yu. Khomenko, A. V. Yagoda, V. T. Ivashkin |
| |
| Vol 28, No 1 (2018) |
Clinical role of endothelial dysfunction and hemostasis gene allelic variants in hepatitis C virus-associated cryoglobulinemia |
Abstract
PDF (Rus)
|
|
M. V. Sokolova, Ye. Ye. Starostina, T. N. Krasnova, L. M. Samokhodskaya, T. P. Rozina, V. G. Avdeyev, M. G. Artemova, Ye. B. Yarovaya, N. A. Mukhin |
| |
| Vol 27, No 1 (2017) |
The role of non-alcoholic fatty liver disease in the formation of atherosclerotic vascular lesions in patients with abdominal obesity |
Abstract
PDF (Rus)
|
|
N. L. Denisov, V. B. Grinevich, Ye. V. Chernetsova, Yu. A. Kravchuk, K. V. Ivashkin |
| |
| Vol 28, No 1 (2018) |
Differentiated approach at the choice of chronic hepatitis C antiviral therapy mode (real clinical practice experience) |
Abstract
PDF (Rus)
|
|
I. Yu. Pirogova, N. B. Kovaleva, E. P. Patlusov, E. S. Radchenko |
| |
| Vol 27, No 1 (2017) |
Liver cirrhosis epidemiology in Chelyabinsk region in 2006-2015 |
Abstract
PDF (Rus)
|
|
A. I. Dolgushina, Ye. R. Olevskaya, A. N. Tarasov, M. S. Kazakova, A. Yu. Markina |
| |
| Vol 28, No 1 (2018) |
Alaninaminotransferase and specific viral hepatitis markers in the blood of donors |
Abstract
PDF (Rus)
|
|
Zh. K. Burkitbayev, G. A. Yesenbayeva, S. A. Abdrakhmanova, Zh. Zh. Bibekov, Ye. B. Zhiburt |
| |
| Vol 27, No 2 (2017) |
Seronegative autoimmune hepatitis |
Abstract
PDF (Rus)
|
|
A. O. Buyeverov |
| |
| Vol 27, No 2 (2017) |
Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12) |
Abstract
PDF (Rus)
|
|
V. T. Ivashkin, I. G. Bakulin, P. O. Bogomolov, M. V. Matsiyevich, N. I. Geyvandova, P. V. Koroy, S. V. Nedogoda, O. A. Sablin, L. G. Lenskaya, Ye. V. Beloborodova, A. A. Bagretsova, R. A. Abdulkhakov, M. F. Osipenko, I. V. Osipova, D. A. Pocheptsov, Ye. V. Chumachek, O. M. Khromtsova, Ye. V. Kuzmicheva |
| |
| Vol 27, No 2 (2017) |
The effect of Clostridium difficile infection on the course of liver cirrhosis |
Abstract
PDF (Rus)
|
|
A. A. Driga, M. V. Mayevskaya, V. T. Ivashkin |
| |
| Vol 27, No 3 (2017) |
Small intestinal bacterial overgrowth syndrome and systemic inflammation in pathogenesis of hemodynamic changes at liver cirrhosis |
Abstract
PDF (Rus)
|
|
R. V. Maslennikov, A. A. Driga, K. V. Ivashkin, M. S. Zharkova, M. V. Mayevskaya, Ch. S. Pavlov, M. G. Arslanyan, N. B. Musina, Ye. N. Berezina, V. T. Ivashkin |
| |
| Vol 27, No 3 (2017) |
Efficacy and safety of glycyrrhizic acid and essential phospholipids (Phosphogliv) combination for alcoholic liver disease: results of the double-blind randomized placebo-controlled multicenter post-registration (phase IV) clinical trial «Jaguar» (PHG-M2/P03-12) |
Abstract
PDF (Rus)
|
|
I. G. Bakulin, N. A. Bokhan, P. O. Bogomolov, N. I. Geyvandova, M. V. Matsiyevich, M. A. Vinnikova, V. G. Morozov, O. M. Khromtsova, G. S. Soldatova, O. Yu. Shiryayev, R. D. Ilyuk, K. V. Rybakova, A. G. Katkovskaya, S. V. Teplykh, A. A. Bagretsova, M. V. Krasnova, Ye. V. Alekseyeva, A. V. Anipchenko, Ye. V. Baskakov |
| |
| Vol 27, No 4 (2017) |
Efficacy and safety of 3D-therapy at HCV-related subcompensated liver cirrhosis (genotype 1b) |
Abstract
PDF (Rus)
|
|
P. O. Bogomolov, M. V. Matsiyevich, A. O. Buyeverov, V. D. Beznosenko, Ye. V. Fedosova, M. Yu. Petrachenkova, S. V. Koblov, K. Yu. Kokina, O. S. Kuzmina, N. V. Voronkova |
| |
| Vol 27, No 4 (2017) |
The impact of bacterial overgrowth syndrome and systemic inflammation on abdominal hemodynamics in liver cirrhosis |
Abstract
PDF (Rus)
|
|
R. V. Maslennikov, M. A. Tatarkina, M. V. Mayevskaya, Ch. S. Pavlov, M. S. Zharkova, V. T. Ivashkin |
| |
| Vol 27, No 5 (2017) |
Principles of diuretic therapy at liver cirrhosis |
Abstract
PDF (Rus)
|
|
A. I. Dyadyk, T. Ye. Kugler, I. S. Malovichko, N. F. Yarovaya, I. V. Rakitskaya |
| |
| Vol 26, No 4 (2016) |
Options of dyslipidemia treatment at non-alcoholic fatty liver disease |
Abstract
PDF (Rus)
|
|
M. V. Mayevskaya, M. A. Morozova |
| |
| Vol 27, No 5 (2017) |
Urinary tract infections in patients with decompensated liver cirrhosis, listed for liver transplantation |
Abstract
PDF (Rus)
|
|
P. D. Bessonov, I. V. Borzunov, E. N. Bessonova |
| |
| Vol 26, No 4 (2016) |
Liver and spleen elastography in diagnosis of extrahepatic portal vein obstruction: pilot study |
Abstract
PDF (Rus)
|
|
M. Yu. Nadinskaya, Ye. O. Liusina, Ch. S. Pavlov |
| |
| Vol 27, No 5 (2017) |
Efficacy of daclatasvir and asunaprevir for viral hepatitis С in two donor lung recipients |
Abstract
PDF (Rus)
|
|
D. T. Abdurakhmanov, Ye. . Sidorova, I. N. Tikhonov, N. A. Mukhin, V. T. Ivashkin |
| |
| Vol 26, No 4 (2016) |
Treatment of liver cirrhosis complications: Clinical guidelines of the Russian Scientific Liver Society and Russian gastroenterological association |
Details
PDF (Rus)
|
|
V. T. Ivashkin, M. V. Mayevskaya, Ch. S. Pavlov, Ye. A. Fedosyina, Ye. N. Bessonova, I. Yu. Pirogova, D. V. Garbuzenko |
| |
| Vol 27, No 6 (2017) |
Efficacy and safety of the Russian protease inhibitor narlaprevir at treatment-naive and earlier treated noncirrhotic patients with the 1st genotype chronic hepatitis C (PIONEER study) |
Abstract
PDF (Rus)
|
|
M. V. Mayevskaya, V. T. Ivashkin, O. O. Znoyko, Ye. A. Klimova, D. T. Abdurakhmanov, I. G. Bakulin, P. O. Bogomolov, E. Z. Burnevich, M. Yu. Galushko, N. I. Geyvandova, K. V. Zhdanov, Ye. V. Esaulenko, S. N. Kizhlo, D. Yu. Konstantinov, N. I. Mironova, V. G. Morozov, Ye. A. Strebkova, I. G. Nikitin, M. F. Osipenko, V. D. Pasechnikov, O. I. Sagalova, I. M. Khayertynova, V. P. Chulanov, A. A. Yakovlev, I. A. Vasyutin, Ye. P. Tarkhova, E. N. Krasavina, M. Yu. Samsonov |
| |
| Vol 26, No 5 (2016) |
The clinical role of blood coagulation and platelet receptors gene allelic variants in development of cryoglobulinemic vasculitis at chronic hepatitis C |
Abstract
PDF (Rus)
|
|
Yekaterina Ye. Starostina, M. V. Sokolova, L. M. Samokhodskaya, T. П. Rozina, T. N. Krasnova, Ye. B. Yarovaya, N. A. Mukhin |
| |
| Vol 27, No 6 (2017) |
The modern options of chronic hepatitis C antiviral therapy with daclatasvir: results of named patient program |
Abstract
PDF (Rus)
|
|
V. T. Ivashkin, M. V. Mayevskaya, D. T. Abdurakhmanov, I. G. Bakulin, N. I. Geyvandova, M. L. Zubkin, S. N. Kizhlo, A. V. Kuznetsova, I. B. Latysheva, N. A. Mamonova, V. G. Morozov, O. I. Sagalova, Ye. V. Esaulenko, Ye. O. Lyusina |
| |
| 1 - 112 of 112 Items |
|
